$8.38
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Lifeward Ltd. is a medical device company, which engages in the design, development and marketing of wearable robotic exoskeletons. The company is headquartered in Yokneam, Northern (Hazafon) and currently employs 81 full-time employees. The company went IPO on 2014-09-12. The firm is engaged in designing, developing, and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk again. The firm offers an exoskeleton that uses its tilt-sensor technology and an onboard computer and motion sensors to drive motorized legs that power movement. Lifeward designs are intended for people with paraplegia, a spinal cord injury resulting in complete or incomplete paralysis of the legs, having the use of their upper bodies and arms. The firm offers multiple products: ReWalk Personal, ReStore Exo-Suit, MYOLYN FES Cycling, and AlterG Anti-Gravity Systems. ReWalk Personal is designed for everyday use by paraplegic individuals at home and in their communities and is custom-fitted for each user. Lifeward Rehabilitation products are for use by paraplegia patients in the clinical rehabilitation environment.
Country

IL

CEO

Mr. Mark Grant

IPO date

2014

Employees

81

ISIN

IL0011331076

Key stats

Open

$8.50

Volume

9.30K

Market cap

$23.75M

Prev. close

$8.44

Impl / hst vl

-

Open interest

$0.00

$8.23

Day’s Range

$8.50

$0.35

52W Range

$9.61

Valuation

50
Valuation score
Fairly Valued
P/E
-
P/S
1.57
P/B
3.69
Current ratio
2.40
Debt / Equity
-0.66
ROE
-243.14%
Gross margin
34.21%
Income growth
101.81%
FCF growth
3.06

Analysts estimates

Consensus rating
Buy

The average rating from top 5 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$20.40
The top 4 analysts forecasts that 12-month price may increase by 143.44%, with a low of $10.10 and a high of $31.50
$10.10
Low
$20.40
Avg
$31.50
High
Current price

Earnings

Q1 ‘26 revenue
$3.92M
Q1 ‘26 net income
-$10.79M
Revenue
Net income
Previous EPS
-$3.13
Estimate EPS
-$1.37
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply